Gilead Sciences Inc buy BMO Capital Markets
Start price
12.02.25
/
50%
€100.00
Target price
12.02.26
€110.81
Performance (%)
9.18%
Price
30.12.25
€106.02
Summary
This prediction is currently active. With a performance of 9.18%, the BUY prediction by BMO_Capital_Markets for Gilead Sciences Inc is trending in the right direction. Dividends of €3.16 are taken into consideration when calculating the performance. This prediction currently runs until 12.02.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Gilead Sciences Inc | -0.151% | -0.151% |
| iShares Core DAX® | 0.794% | 2.841% |
| iShares Nasdaq 100 | 0.016% | -0.939% |
| iShares Nikkei 225® | 0.309% | -0.648% |
| iShares S&P 500 | 0.181% | -0.442% |
Comments by BMO_Capital_Markets for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) had its price target raised by analysts at BMO Capital Markets from $110.00 to $115.00. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€105.20
20.10.25
20.10.25
€115.78
20.10.26
20.10.26
1.53%
30.12.25
30.12.25
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€89.58
07.11.24
07.11.24
€94.44
07.11.25
07.11.25
15.85%
08.11.25
08.11.25
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€80.64
17.10.24
17.10.24
€86.86
17.10.25
17.10.25
30.46%
18.10.25
18.10.25
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€73.00
16.05.23
16.05.23
€91.88
16.05.24
16.05.24
-14.51%
17.05.24
17.05.24